Position
Chief Commercial Officer
Company
Adverum Biotechnologies
Redwood CityBiotechnologyHealth CareMedicalTherapeuticsDescription
Adverum Biotechnologies, Inc has announced the appointment of Jason L Mitchell as chief commercial officer. In this role, Mr Mitchell will be responsible for setting the launch strategy and building the commercial infrastructure for ixoberogene soroparvovec (Ixo-vec), the company’s potential one-time intravitreal (IVT) injection for the treatment of neovascular or wet age-related macular degeneration (wet AMD).
Quick answer
Adverum Biotechnologies Appoints Jason L. Mitchell as Chief Commercial Officer (October 17, 2024). Adverum Biotechnologies is based in Redwood City, California, United States.
- Who is the new Chief Commercial Officer at Adverum Biotechnologies?
- Adverum Biotechnologies named Jason L. Mitchell Chief Commercial Officer, announced October 17, 2024.
- What did Adverum Biotechnologies announce on October 17, 2024?
- Adverum Biotechnologies, Inc has announced the appointment of Jason L Mitchell as chief commercial officer. In this role, Mr Mitchell will be responsible for setting the launch strategy and building the commercial infrastructure for ixoberogene soroparvovec (Ixo-vec), the company’s potential one-time intravitreal (IVT) injection for the treatment of neovascular or wet age-related macular degeneration (wet AMD).
- What does Adverum Biotechnologies do?
- At Adverum, we are driven to establish gene therapy as a new standard of care for debilitating ocular diseases.
- Where is Adverum Biotechnologies based?
- Adverum Biotechnologies is based in Redwood City, California, United States.
- Which similar companies made leadership changes around the same time?
- Parexel (October 22, 2024), Immunome Inc. (October 8, 2024), Actinogen Medical (October 29, 2024) and Aethlon Medical (October 3, 2024) also announced leadership changes within 45 days of Adverum Biotechnologies.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Parexel Appoints Keri Mattox as Chief Business Officer (October 22, 2024)
- Immunome Appoints Roee Shahar as Executive Vice President, Commercial (October 8, 2024)
- Actinogen Medical Appoints Andrew Udell as Chief Commercial Officer reporting to CEO Dr Steven Gourlay (October 29, 2024)
- Aethlon Medical Elevates James B. Frakes to Permanent Chief Executive Officer (October 3, 2024)
- Greywolf Therapeutics Appoints Darlene Deptula-Hicks as Chief Financial Officer (November 14, 2024)
- ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer (November 14, 2024)
Who to call at Adverum Biotechnologies, and when
A new leader at Adverum Biotechnologies brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Adverum Biotechnologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Adverum Biotechnologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Adverum Biotechnologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Adverum Biotechnologies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Adverum Biotechnologies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.